MONOCLONAL ANTIBODY FOR CANCER TREATMENT (Q3133637): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the infer coords bot - inferring coordinates from location) |
(Changed an Item: Edited by the materialized bot - inferring region from the coordinates) |
||
| Property / contained in NUTS | |||
| Property / contained in NUTS: Madrid / rank | |||
Normal rank | |||
Revision as of 11:56, 10 October 2021
Project Q3133637 in Spain
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MONOCLONAL ANTIBODY FOR CANCER TREATMENT |
Project Q3133637 in Spain |
Statements
2,812,369.5 Euro
0 references
5,624,739.0 Euro
0 references
50.0 percent
0 references
16 February 2015
0 references
14 December 2015
0 references
ALTHIA HEALTH S.L.
0 references
40°25'0.12"N, 3°42'12.89"W
0 references
28079
0 references
VALIDACIÓN DE UN ANTICUERPO MONOCLONAL PARA LA DETECCIÓN Y TRATAMIENTO DE CÉLULAS MADRE DEL CÁNCER EN TUMORES DE CEREBRO (Spanish)
0 references
VALIDATION OF A MONOCLONAL ANTIBODY FOR THE DETECTION AND TREATMENT OF CANCER MOTHER CELLS IN BRAIN TUMORS (English)
0 references
Madrid
0 references
Identifiers
DGEPF/01/21/002-17/18
0 references